Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
189 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Psoriasis" (189 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Riboflavin;   Other: Placebo
2 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
3 Recruiting Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
Condition: Psoriasis
Intervention:
4 Recruiting BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
Condition: Psoriasis
Interventions: Drug: BAY1003803;   Drug: Clobetasol propionate;   Drug: Betamethasone/calcipotriene
5 Recruiting To Evaluate the Safety, Tolerability and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2-11) With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: STF 115469 Foam;   Drug: Vehicle Foam
6 Recruiting Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
Condition: Psoriasis
Intervention:
7 Recruiting LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
Condition: Psoriasis Vulgaris
Interventions: Drug: LEO 32731;   Drug: LEO 32731 Placebo
8 Recruiting To Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Calcipotriene 0.005%, Applied Under Maximal Use Conditions in 12-16 Year Olds With Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: calcipotriene
9 Not yet recruiting Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: Metformin;   Drug: Placebo;   Drug: Topical Coal tar;   Drug: Topical calcipotriol
10 Recruiting Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis;   Other: Sodium Nitroprussiate iontophoresis;   Other: ppi water iontophoresis;   Other: Laser Doppler recording
11 Recruiting Excimer Laser, Serum Markers & Psoriasis
Condition: Psoriasis
Intervention: Device: Excimer laser treatment
12 Recruiting Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab;   Drug: Ustekinumab
13 Recruiting Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
Condition: Psoriasis Vulgaris
Intervention: Drug: Methotrexate
14 Recruiting Psychotherapy for Patients With Psoriasis: Effects in Quality of Life
Condition: Psoriasis
Intervention: Behavioral: Psychotherapy
15 Not yet recruiting Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Condition: Scalp Psoriasis
Interventions: Drug: 0.25% Desoximetasone cream (Topoxy®);   Drug: 0.25% Desoximetasone cream (Topicorte®);   Drug: Placebo
16 Not yet recruiting International Clinical Trial to Evaluate Efficacy and Safety of Multiple Injections of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: BCD-085;   Other: Placebo
17 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
18 Recruiting An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than 6 to Less Than 12 Years of Age
Condition: Psoriasis
Interventions: Drug: Ustekinumab 0.75 mg/kg;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg
19 Not yet recruiting Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Interventions: Drug: PF-06700841;   Other: Placebo
20 Not yet recruiting Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: 0.5% Icotinib hydrochloride cream;   Drug: 1.0% Icotinib hydrochloride cream;   Drug: 2.0% Icotinib hydrochloride cream;   Drug: 4.0% Icotinib hydrochloride cream;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.